TXG - 10x Genomics, Inc.
IEX Last Trade
14.67
-0.105 -0.716%
Share volume: 22,497
Last Updated: Thu 26 Dec 2024 08:30:21 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$14.78
-0.11
-0.71%
Fundamental analysis
22%
Profitability
4%
Dept financing
7%
Liquidity
75%
Performance
30%
Performance
5 Days
-0.41%
1 Month
-2.27%
3 Months
-34.22%
6 Months
-24.77%
1 Year
-74.05%
2 Year
-57.16%
Key data
Stock price
$14.67
DAY RANGE
$14.17 - $14.98
52 WEEK RANGE
$13.46 - $57.78
52 WEEK CHANGE
-$74.51
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Serge Saxonov
Region: US
Website: 10xgenomics.com
Employees: 1,240
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: 10xgenomics.com
Employees: 1,240
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression.
Recent news